Tata Elxsi Q1: revenue +14.5% YoY beats guidance pace, PAT ₹171 Cr up 18%, margins firm YoY
PAT +18.17% YoY · revenue +14.46% · margins expanding
₹1,021.11 Cr
+14.46% YoY
₹170.6 Cr
+18.17% YoY
16.06%
+0.5pp YoY
₹27.38
Tata Elxsi opened FY27 with a clean reacceleration on a standalone basis (its only reporting basis — no subsidiaries). Revenue from operations rose to ₹1,021.1 Cr, up 14.5% YoY from ₹892.1 Cr and up 2.8% sequentially, comfortably ahead of the high-single-digit full-year growth pace management guided to on the Q4 concall. Net profit came in at ₹170.6 Cr, up 18.2% YoY from ₹144.4 Cr, with EPS at ₹27.38 versus ₹23.18 a year ago. There were no exceptional items either this quarter or in the year-ago quarter, so the growth is fully underlying — the ₹95.7 Cr New Labour Codes charge that dented FY26 sat in Q3, not in these comparatives.
Q1 FY-2027 vs prior quarters
The margin picture is a YoY-versus-QoQ split. Against last year, both net margin (16.7% vs 15.5%) and operating/EBITDA margin (~21.2% vs 20.9%) expanded modestly. Sequentially, however, profit fell 22.6% off an unusually strong Q4 (₹220.4 Cr PAT, 21.1% NPM, 24.6% OPM) that carried richer other income (₹50.6 Cr vs ₹41.5 Cr) and peak margins — so Q1 reads as a seasonally soft, normalised quarter rather than a deterioration. By segment, Software development & services delivered ₹992.3 Cr (+13.7% YoY) and the small System integration & support business grew ₹28.8 Cr (+46.8% YoY), swinging from a ₹2.6 Cr year-ago segment loss to a ₹3.1 Cr profit.
The stock went into the print at ₹3,697.3, down 9% over the past month of trading.
For context: revenue is at a 6-quarter high.
What the summary numbers don't show
Audited, unmodified auditor opinion — standalone only (no subsidiary/associate/JV); first result under new CFO Nalin Rana.
Management has tempered its full-year FY27 outlook, now guiding for high single-digit revenue growth, a revision from previous double-digit aspirations, citing geopolitical uncertainty. They are hopeful for a recovery in the Healthcare vertical from Q1 after a sharp decline due to deal delays. The company will continue
— This quarter: beat
No specific Q1 FY27 street consensus surfaced in our search (previews were qualitative, flagging a seasonally weak quarter and geopolitical headwinds), so a beat/miss call against consensus is unavailable. Against management's own framing, the topline is running ahead of the tempered high-single-digit FY27 guide, but the stated ~27% exit-PBT-margin target for Q4 FY27 remains a distance away — PBT margin this quarter was ~22.8% of revenue. Management had also flagged a hoped-for Healthcare recovery from Q1 after Q4's sharp deal-delay-driven decline; the vertical split isn't in this filing and is the key item for the 7pm concall. The quarter's corporate backdrop was light on financial impact: a ₹1.58 Cr tax demand notice (immaterial), the Sky/NEURON autonomous-networks partnership, and the FY26 ₹75 dividend/AGM cycle; this is also the first print under new CFO Nalin Rana.
What to watch
W1
Healthcare vertical recovery: management guided a Q1 rebound after Q4's ~13% CC QoQ decline — verify in the concall vertical split, absent from this filing.
W2
PBT-margin trajectory toward the ~27% Q4 FY27 exit target (currently ~22.8% of revenue) — the main margin checkpoint for the year.
W3
Full-year revenue vs the high-single-digit guide: Q1 ran at +14.5% YoY — watch whether it sustains given the cited geopolitical headwinds.
Clean digital PDF, clear headers, all arithmetic ties (1021.11+41.46=1062.57 income; 1062.57-830.11=232.46 PBT; 232.46-61.86=170.60 PAT). No exceptional item this quarter; the ₹95.69 Cr New Labour Codes charge sat in Q3/FY26 full-year only, so Q1-on-Q1 comparison is clean (adjusted=raw). Standalone only — no subsidiary/associate/JV. Unmodified audit opinion.
Informational and educational content only. Not investment advice.